avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tcf7 | mm10_v2_chr11_-_52282564_52282579 | 0.77 | 4.3e-08 | Click! |
Tcf7l2 | mm10_v2_chr19_+_55894508_55894534 | 0.55 | 4.8e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_145805862 Show fit | 9.49 |
ENSMUST00000067479.5
|
cytochrome P450, family 3, subfamily a, polypeptide 44 |
|
chr14_-_56062307 Show fit | 8.01 |
ENSMUST00000043249.8
|
mast cell protease 4 |
|
chr5_-_145469723 Show fit | 6.58 |
ENSMUST00000031633.4
|
cytochrome P450, family 3, subfamily a, polypeptide 16 |
|
chr6_-_40999479 Show fit | 5.33 |
ENSMUST00000166306.1
|
predicted gene 2663 |
|
chr7_+_13733502 Show fit | 4.65 |
ENSMUST00000086148.6
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
|
chr3_-_107239707 Show fit | 4.49 |
ENSMUST00000049852.8
|
prokineticin 1 |
|
chr17_+_25366550 Show fit | 4.25 |
ENSMUST00000069616.7
|
tryptase beta 2 |
|
chr7_-_13989588 Show fit | 3.83 |
ENSMUST00000165167.1
ENSMUST00000108520.2 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 4 |
|
chr8_-_111691002 Show fit | 3.71 |
ENSMUST00000034435.5
|
chymotrypsinogen B1 |
|
chr11_+_108920800 Show fit | 3.65 |
ENSMUST00000140821.1
|
axin2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.0 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
2.1 | 6.3 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.0 | 5.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 4.9 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.6 | 4.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 4.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 3.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 2.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 2.9 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 2.8 | GO:0007586 | digestion(GO:0007586) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 27.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 18.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 7.2 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 4.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 3.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 2.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 2.2 | GO:0005844 | polysome(GO:0005844) |
0.7 | 2.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 1.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 1.8 | GO:0016460 | myosin II complex(GO:0016460) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 23.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
2.6 | 20.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 8.6 | GO:0008083 | growth factor activity(GO:0008083) |
1.0 | 7.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 6.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 5.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 4.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 3.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 3.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 3.4 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 6.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 4.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 4.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 3.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 2.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 2.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 1.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |